Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2007 by Boston Children’s Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Schering-Plough
Progeria Research Foundation
Information provided by:
Boston Children’s Hospital
ClinicalTrials.gov Identifier:
NCT00425607
First received: January 22, 2007
Last updated: December 24, 2007
Last verified: December 2007